Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $52.13 Consensus Target Price from Brokerages
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1-year price objective among analysts […]
More Stories
Embracer Group AB (publ) (LON:0GFE) Shares Down 3.1% – Time to Sell?
Embracer Group AB (publ) (LON:0GFE – Get Free Report)’s stock price traded down 3.1% on Monday . The company traded...
D2L (OTCMKTS:DTLIF) Stock Price Down 0.8% – Here’s What Happened
D2L Inc. (OTCMKTS:DTLIF – Get Free Report)’s stock price traded down 0.8% on Monday . The stock traded as low...
Manila Water (OTCMKTS:MWTCY) Stock Price Down 4.8% – Should You Sell?
Manila Water Company, Inc. (OTCMKTS:MWTCY – Get Free Report) dropped 4.8% during mid-day trading on Monday . The company traded...
Contrasting Edap Tms (NASDAQ:EDAP) & Cosmos Health (NASDAQ:COSM)
Cosmos Health (NASDAQ:COSM – Get Free Report) and Edap Tms (NASDAQ:EDAP – Get Free Report) are both small-cap medical companies,...
AFC Energy (OTCMKTS:AFGYF) Stock Price Up 6.4% – Here’s Why
AFC Energy plc (OTCMKTS:AFGYF – Get Free Report)’s share price was up 6.4% on Monday . The stock traded as...
pzETH (PZETH) Price Down 3.9% Over Last 7 Days
pzETH (PZETH) traded down 4.1% against the U.S. dollar during the one day period ending at 23:00 PM E.T. on...